| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |